Treatment Experience – A mother’s story by The Coffee Klatch | Blog Talk Radio

For any parent raising a child affected by bipolar disorder, this is an invaluable interview. This interview provides a complete description of the FOH phenotype and clarifies the confusion caused by DSM controversies. An overview of the intranasal ketamine clinical study is presented by the study’s coordinator, Alyssa Bronsteen. MOST IMPORTANT: this is your chance…

Recruiting for Treatment Study – video

This is a video that documents the experiences of three children who have participated in the pilot study of intranasal ketamine as a treatment for juvenile bipolar disorder. Dr. Demitri Papolos, Director of Research for JBRF, developed and implemented a pilot study to explore the efficacy of intranasal ketamine as a treatment for children who…

Press Release: FDA Approval

Maplewood, NJ – November 3, 2011The Juvenile Bipolar Research Foundation (“JBRF”) announced today that the Federal Drug Administration (“FDA”) has approved its submission of a request to study the use of intranasal ketamine in the treatment of children ages 6-12 with bipolar disorder who also have an identifiable biological marker associated with body temperature dysregulation.…